BASi Names Dr. Gregory C. Davis to Board of Directors
PRESS RELEASE UPDATED: JUN 20, 2017 WEST LAFAYETTE, IN, June 20, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that the board of directors unanimously elected Dr. Gregory C. Davis as a director effective June 14, 2017. This action brings the number of directors to four. Larry Boulet, BASi’s Chairman... Read more